Opana Buyers Seek Class Cert. In Pay-For-Delay Row
By Christopher Cole ( April 9, 2019, 6:29 PM EDT) -- Medication buyers who claim they overpaid for the painkiller Opana ER are asking an Illinois federal judge to certify two classes among them as part of multidistrict litigation over what they describe as a pay-for-delay scheme to keep a generic version off the shelves....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.